Skip to search formSkip to main contentSkip to account menu

darbepoetin alfa

Known as: DARBEPOETIN ALFA,RECOMBINANT, Novel Erythropoiesis Stimulating Protein, Darbepoetin 
A recombinant analog of the endogenous cytokine erythropoietin, an erythropoiesis-stimulating protein. Due to the addition of two carbohydrate chains… 
National Institutes of Health

Related topics

Related topics

20 relations
0.4 ML darbepoetin alfa 0.025 MG/ML Prefilled Syringe [Aranesp]0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe [Aranesp]AnemiaB-Cell Activation

Narrower (3)

AranespKRN 321Nespo

Broader (1)

Hematinics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Prevalencia de anemia y su manejo clínico en la enfermedad renal crónica estadios 3-5 no en diálisis en Cataluña: estudio MICENAS I
Introduccion: La anemia es una complicacion frecuente de la enfermedad renal cronica (ERC). El objetivo de este estudio fue… 
2010
2010
Darbepoetin Alfa and Chronic Kidney Disease
  • 2010
  • Corpus ID: 20606956
To the Editor: Pfeffer et al. (Nov. 19 issue)1 report on the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT… 
2008
2008
Changes in RBC supportive medications and transfusions in cancer patients undergoing chemotherapy before and after FDA and Medicare actions in 2007
20595 Background: In 2007, changes occurred to restrict the use and reimbursement of RBC supportive medications in cancer… 
2008
2008
Switch of ESA therapy from darbepoetin-alpha to epoetin-beta in hemodialysis patients: a single-center experience.
AIMS No study has previously investigated a switch from darbepoetin-alpha to epoetin-beta in unselected dialysis patients. Our… 
2008
2008
Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
In anemic patients with heart failure (HF), erythropoietin-type drugs can elicit clinical improvement. This study examined the… 
Review
2005
Review
2005
Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin α, epoetin β and darbepoetin α use in routine clinical practice
This retrospective observational survey assessed, in a routine clinical practice setting, the modalities of treatment with… 
2005
2005
An audit comparing subcutaneous epoetin alfa to intravenous darbepoetin alfa in chronic hemodialysis patients
Background. There has been increasing concern over the safety of conventional erythmpoietic agents as the result of cases of… 
Review
2004
Review
2004
Erythropoietin is more than just a promoter of erythropoiesis.
The red cell production is continuously adjusted to cope with the loss of aged blood cells and to guarantee optimal oxygen supply… 
2004
2004
Correction/Maintenance Dosing (Front Loading) of Darbepoetin alfa: Final Results from a Randomized Phase 3 Active Controlled Trial.
Prior research with darbepoetin alfa (DA; Aranesp®) in patients with chemotherapy-induced anemia (CIA) has indicated the… 
2000
2000
Rational design of novel erythropoiesis stimulating protein A super-sialated molecule with increased biological activity